CARE Ratings Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.2 pts more than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CARE Ratings Limited submitted its unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025), reviewed by statutory auditors B S R & Co. LLP with a clean limited review report. On a consolidated basis, revenue from operations rose about 19% year-on-year to ₹9,390.5 lakhs (from ₹7,892 lakhs), while net profit attributable to owners grew around 24% to ₹2,577.85 lakhs (from ₹2,073.48 lakhs). Basic EPS stood at ₹8.61 versus ₹6.84 in the year-ago quarter. On a standalone basis, revenue from operations grew about 16% to ₹7,563.9 lakhs and net profit rose around 21% to ₹2,911.55 lakhs, with standalone basic EPS at ₹9.72. The board also approved the reappointment of Mr. G. Mahalingam and Mr. V. Chandrasekaran as Independent Directors for three years, subject to shareholder approval.
Strong Q1 performance with healthy double-digit growth in both revenue and profit signals improving business momentum. The clean auditor report and director continuity are neutral-to-positive for shareholders, though the YoY growth rates fall just short of the headline thresholds for exceptional growth.